3-deazaneplanocin has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aburatani, H; Hirakawa, Y; Kanki, Y; Mimura, I; Nakaki, R; Nangaku, M; Suzuki, Y; Tanaka, T | 1 |
1 other study(ies) available for 3-deazaneplanocin and Cirrhosis
| Article | Year |
|---|---|
Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes.
Topics: Adenosine; Animals; Biomarkers; Cells, Cultured; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Genome; Humans; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury | 2018 |